How to Get Jatenzo in Maryland

What Is Jatenzo and Why Does It Matter?

Jatenzo is the first oral testosterone undecanoate capsule approved by the FDA for adult males with conditions associated with a deficiency or absence of endogenous testosterone (hypogonadism) 1. The approval in March 2019 gave patients an alternative to injections, gels, and patches.

How Oral Testosterone Undecanoate Works

Unlike older oral androgens such as methyltestosterone, Jatenzo is absorbed through the intestinal lymphatic system, which significantly reduces first-pass liver metabolism 2. This lymphatic absorption pathway is the reason the capsule must be taken with food containing at least 30% fat. In the key trial by Swerdloff et al. (N=166), 87% of men achieved average testosterone concentrations within the normal range (300 to 1,100 ng/dL) by day 90 2.

Why Maryland Patients Choose Oral TRT

For men in Maryland who travel frequently, work in environments where topical gels pose transfer risk, or simply prefer not to self-inject, the oral route removes significant barriers. The Endocrine Society's 2018 clinical practice guideline recognizes multiple testosterone formulations as acceptable first-line therapy, and the choice should reflect patient preference and pharmacokinetics 3.

Step-by-Step: Getting a Jatenzo Prescription in Maryland

The process from initial suspicion of low testosterone to holding a Jatenzo prescription in Maryland follows a predictable clinical path. Here is each stage broken down.

Step 1: Confirm Hypogonadism with Lab Work

The Endocrine Society guideline requires two separate morning serum total testosterone measurements below 300 ng/dL before initiating therapy 3. Blood draws should occur between 7:00 AM and 10:00 AM, when testosterone levels peak. Labs should also include a complete metabolic panel, CBC with hematocrit, PSA (for men over 40), and a lipid panel 4. LH and FSH help differentiate primary from secondary hypogonadism, which can change the clinical approach 3.

Step 2: Consult a Licensed Prescriber

In Maryland, Jatenzo can be prescribed by MDs, DOs, nurse practitioners (NPs with a collaborative practice agreement), and physician assistants (PAs under physician delegation). You do not need to see an endocrinologist specifically. Urologists, primary care physicians, and men's health specialists all commonly prescribe testosterone replacement. Maryland law permits telehealth prescribing for Schedule III controlled substances, so a video consultation is a valid pathway 5.

Step 3: Handle Prior Authorization

Most insurers, including Maryland Medicaid, require prior authorization for Jatenzo. The PA typically asks for documentation of two low testosterone lab results, symptoms consistent with hypogonadism, and confirmation that the patient does not have contraindications such as breast or prostate cancer, untreated polycythemia, or severe cardiac disease 1. Expect the PA process to take 3 to 7 business days. Your provider's office handles the submission.

Step 4: Fill at a Pharmacy

Once approved, Jatenzo can be filled at retail pharmacies, specialty pharmacies, or mail-order pharmacies licensed in Maryland. Some patients use manufacturer copay programs that can reduce out-of-pocket costs to as low as $0 for commercially insured patients, depending on plan design.

Telehealth Access to Jatenzo in Maryland

Telehealth has expanded TRT access significantly in Maryland. The state adopted permanent telehealth parity legislation following the COVID-era expansions, and the Maryland Board of Physicians permits initial evaluations via synchronous audio-video for testosterone prescribing 5.

What a Telehealth Visit Looks Like

A typical telehealth TRT consultation lasts 15 to 25 minutes. The provider reviews your lab results (which you complete at a local draw station beforehand), discusses symptoms, screens for contraindications, and selects a formulation. If Jatenzo is chosen, the prescription is sent electronically to your pharmacy of choice.

Telehealth Limitations to Know

Maryland requires that the prescribing provider hold an active Maryland medical license. Out-of-state telehealth providers cannot prescribe controlled substances to Maryland residents unless they also hold Maryland licensure. The Ryan Haight Act requires that a valid prescriber-patient relationship exist before a CIII substance is prescribed via telemedicine 6. In practice, this means the initial video evaluation satisfies the requirement; you do not need an in-person visit first.

Maryland Medicaid and Commercial Insurance Coverage

Maryland Medicaid covers Jatenzo for diagnosed male hypogonadism with prior authorization. The PA criteria mirror standard clinical guidelines: documented low testosterone on two occasions plus symptomatic presentation 3.

Commercial Plan Coverage

Most commercial insurers in Maryland, including CareFirst BlueCross BlueShield, UnitedHealthcare, and Aetna, list Jatenzo on their formularies, usually on Tier 3 (preferred brand) or Tier 4 (specialty). A 2021 analysis in the Journal of Urology found that prior authorization requirements for TRT were associated with treatment delays of 5 to 12 days on average 7. If a PA is denied, your provider can submit a peer-to-peer appeal. Denial rates for testosterone in commercially insured men with documented hypogonadism are relatively low when labs meet guideline thresholds.

Cost Without Insurance

Without insurance, Jatenzo carries a list price of approximately $600 to $900 per month. The Tolmar copay assistance program and GoodRx-style discount cards can reduce this. A 2022 cost-effectiveness study noted that oral TU had higher acquisition costs than injectable testosterone cypionate but comparable total healthcare costs when accounting for office visits and injection supplies 8.

503A Compounding Pharmacies in Maryland

Maryland licenses 503A compounding pharmacies that can prepare oral testosterone undecanoate formulations. These compounded versions are not FDA-approved Jatenzo, but they contain the same active ingredient.

Key Differences: Brand vs. Compounded

The Jatenzo capsule uses a proprietary self-emulsifying drug delivery system (SEDDS) that optimizes lymphatic absorption 2. Compounded oral TU may not replicate this formulation exactly, which could affect bioavailability. The FDA has stated that compounded drugs are not evaluated for safety, efficacy, or manufacturing consistency the way approved products are 9. Patients considering compounded oral TU should discuss absorption differences with their prescriber.

When Compounding Makes Sense

Compounding may be appropriate when insurance does not cover brand Jatenzo and cost is a barrier, or when a patient needs a dose adjustment not available in standard capsule strengths. Maryland 503A pharmacies can ship within the state and, in some cases, across state lines depending on interstate compounding agreements.

Labs and Monitoring on Jatenzo

Monitoring on Jatenzo differs slightly from injectable testosterone because of its unique pharmacokinetics and the FDA's boxed warning regarding blood pressure elevation 1.

Baseline Labs Before Starting

Before the first dose, providers should obtain: two morning total testosterone levels, CBC with hematocrit, comprehensive metabolic panel, lipid panel, PSA (men over 40), and blood pressure readings 3. The American Urological Association (AUA) also recommends a baseline DEXA scan in men with risk factors for osteoporosis 4.

Ongoing Monitoring Schedule

The Endocrine Society recommends checking testosterone levels and hematocrit at 3 months, 6 months, and then annually 3. Jatenzo's FDA label adds a specific requirement to monitor blood pressure periodically, since the key trial observed systolic increases of approximately 3 to 5 mmHg above placebo in some patients 2. If hematocrit rises above 54%, dose reduction or temporary discontinuation is warranted 10. PSA should be rechecked at 3 to 6 months and then annually per AUA guidance 4.

Dose Titration

Jatenzo starts at 237 mg twice daily. At one month, a trough testosterone level guides titration. If the level falls below 300 ng/dL, the dose increases to 316 mg twice daily. If it exceeds 1,100 ng/dL, it decreases to 158 mg twice daily 1. The one-month check is mandatory; skipping it risks under- or over-dosing.

Safety Considerations Specific to Jatenzo

Jatenzo carries a boxed warning for blood pressure increases and is the only TRT formulation with this specific warning 1. The TRAVERSE trial (N=5,246), the largest cardiovascular safety trial of testosterone therapy, found no increased incidence of major adverse cardiovascular events (MACE) with testosterone treatment compared to placebo in hypogonadal men aged 45 to 80 with cardiovascular risk factors 11.

Who Should Not Take Jatenzo

Absolute contraindications include breast cancer, known or suspected prostate cancer, pregnancy or potential pregnancy exposure, and hematocrit above 54% at baseline 1. Men with uncontrolled hypertension (systolic >160 mmHg) should have BP optimized before starting therapy, given the boxed warning. The Endocrine Society also advises against TRT in men planning fertility within 6 to 12 months, as exogenous testosterone suppresses spermatogenesis 3.

Polycythemia Risk

All testosterone formulations raise hematocrit. A meta-analysis of 15 randomized trials (N=1,957) found injectable testosterone produced a 3.2% absolute hematocrit increase versus 1.4% for transdermal and oral formulations 12. Jatenzo's lower polycythemia risk relative to injections is a clinically relevant advantage for men with borderline-high baseline hematocrit.

Timeline: From First Lab to First Dose

Here is a realistic Maryland-specific timeline.

• Days 1 to 3: Order labs and complete morning blood draw.
• Days 4 to 7: Results return; schedule provider consultation (in-person or telehealth).
• Days 7 to 10: Provider visit, prescription written, PA submitted.
• Days 10 to 17: PA approval (3 to 7 business days); prescription sent to pharmacy.
• Days 17 to 21: Pharmacy fills; pickup or delivery.

Total elapsed time averages 14 to 21 days from first lab draw. Patients with existing lab work and a known provider relationship can compress this to 7 to 10 days.

Transferring a Jatenzo Prescription to Maryland

If you have an active Jatenzo prescription from another state, your Maryland pharmacy can process a transfer, but there are specifics. The prescribing provider must either hold a Maryland license or your new Maryland provider must write a new prescription. Controlled substance prescription transfers across state lines follow DEA regulations, and Maryland Board of Pharmacy rules allow one-time CIII transfers between pharmacies 13. The simplest path is to establish care with a Maryland-licensed provider and have them write a new prescription based on your existing records.

Choosing the Right Provider in Maryland

Not all providers are equally familiar with oral TU. Ask three questions during your first interaction.

Does the practice prescribe Jatenzo specifically, not just injectable testosterone? Have they handled Jatenzo prior authorizations with your insurance? Do they offer a one-month follow-up lab check for dose titration? A provider who answers yes to all three will minimize delays and dosing errors. The AUA guidelines emphasize that clinician experience with the specific formulation improves outcomes and adherence 4.